On the other hand, CD4 T cells in the interface of vehicle-treated samples interacted strongly with regulatory T cells that can play a role in suppressing T cell activation; this interaction was lost in the MRTX1257 treated samples as the number of regulatory T cells in the tumour did not increase in all but one of the tumours assessed. The gene discussed is CD4; the disease is neoplasm.